ACADIA Pharmaceuticals Stock Options
| ACAD Stock | USD 17.57 0.05 0.29% |
ACADIA Pharmaceuticals' latest option contracts expiring on March 21st 2025 are carrying combined implied volatility of 0.71 with a put-to-call open interest ratio of 0.68 over 37 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on March 21st 2025.
Open Interest Against March 21st 2025 Option Contracts
2025-03-21
The chart above shows ACADIA Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. ACADIA Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for ACADIA Pharmaceuticals' option, there is no secondary market available for investors to trade.
ACADIA Pharmaceuticals Maximum Pain Price Across 2025-03-21 Option Contracts
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as ACADIA Pharmaceuticals close to expiration to expire worthless. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, ACADIA Pharmaceuticals' option sellers may reap the most after selling more options than buying, causing them to expire worthless.
In The Money vs. Out of Money Option Contracts on ACADIA Pharmaceuticals
Analyzing ACADIA Pharmaceuticals' in-the-money options over time can help investors to take a profitable long position in ACADIA Pharmaceuticals regardless of its overall volatility. This is especially true when ACADIA Pharmaceuticals' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money ACADIA Pharmaceuticals' options could be used as guardians of the underlying stock as they move almost dollar for dollar with ACADIA Pharmaceuticals' stock while costing only a fraction of its price.
ACADIA Pharmaceuticals' stock options are financial instruments that give investors the right to buy or sell shares of ACADIA Pharmaceuticals common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell ACADIA stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If ACADIA Pharmaceuticals' stock price goes up or down, the stock options follow.
At present, ACADIA Pharmaceuticals' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 904.4 M, whereas Stock Based Compensation is forecasted to decline to about 56.8 M. ACADIA Pharmaceuticals In The Money Call Balance
When ACADIA Pharmaceuticals' strike price is surpassing the current stock price, the option contract against ACADIA Pharmaceuticals stock is said to be in the money. When it comes to buying ACADIA Pharmaceuticals' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on ACADIA Pharmaceuticals are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
ACADIA Current Options Market Mood
ACADIA Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps ACADIA Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most ACADIA Pharmaceuticals' options investors are not very successful. ACADIA Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current ACADIA contract
Base on the Rule 16, the options market is currently suggesting that ACADIA Pharmaceuticals will have an average daily up or down price movement of about 0.0444% per day over the life of the 2025-03-21 option contract. With ACADIA Pharmaceuticals trading at USD 17.57, that is roughly USD 0.007797. If you think that the market is fully incorporating ACADIA Pharmaceuticals' daily price movement you should consider buying ACADIA Pharmaceuticals options at the current volatility level of 0.71%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
ACADIA |
Purchasing ACADIA Pharmaceuticals options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" ACADIA calls. Remember, the seller must deliver ACADIA Pharmaceuticals stock to the call owner when a call is exercised.
ACADIA Pharmaceuticals Option Chain
When ACADIA Pharmaceuticals' strike price is surpassing the current stock price, the option contract against ACADIA Pharmaceuticals stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
ACADIA Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on ACADIA. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for ACADIA. It also shows strike prices and maturity days for a ACADIA Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | ACAD250321C00010000 | 12 | 10.0 | 6.6 - 9.5 | 7.6 | In |
Call | ACAD250321C00013000 | 13 | 13.0 | 3.3 - 6.4 | 5.6 | In |
Call | ACAD250321C00014000 | 38 | 14.0 | 3.1 - 5.5 | 5.2 | In |
Call | ACAD250321C00015000 | 76 | 15.0 | 2.2 - 4.4 | 2.85 | In |
Call | ACAD250321C00016000 | 165 | 16.0 | 2.15 - 2.45 | 2.1 | In |
Call | ACAD250321C00017000 | 317 | 17.0 | 1.35 - 1.95 | 1.85 | In |
Call | ACAD250321C00018000 | 508 | 18.0 | 1.05 - 1.25 | 1.2 | Out |
Call | ACAD250321C00019000 | 323 | 19.0 | 0.7 - 0.85 | 0.53 | Out |
Call | ACAD250321C00020000 | 200 | 20.0 | 0.4 - 0.6 | 0.5 | Out |
Call | ACAD250321C00021000 | 0 | 21.0 | 0.2 - 0.4 | 0.2 | |
Call | ACAD250321C00022000 | 140 | 22.0 | 0.0 - 1.0 | 0.28 | Out |
Call | ACAD250321C00023000 | 3 | 23.0 | 0.0 - 1.95 | 0.35 | Out |
Call | ACAD250321C00024000 | 1 | 24.0 | 0.05 - 1.7 | 0.6 | Out |
Call | ACAD250321C00025000 | 28 | 25.0 | 0.0 - 0.6 | 0.2 | Out |
Call | ACAD250321C00026000 | 0 | 26.0 | 0.0 - 2.0 | 0.1 | |
Call | ACAD250321C00027000 | 7 | 27.0 | 0.0 - 0.95 | 0.25 | Out |
Call | ACAD250321C00030000 | 0 | 30.0 | 0.05 - 0.55 | 0.05 | |
Call | ACAD250321C00035000 | 5 | 35.0 | 0.0 - 0.15 | 0.09 | Out |
Put | ACAD250321P00010000 | 1 | 10.0 | 0.0 - 2.0 | 0.27 | Out |
Put | ACAD250321P00012000 | 87 | 12.0 | 0.0 - 0.95 | 0.75 | Out |
Put | ACAD250321P00013000 | 6 | 13.0 | 0.05 - 1.75 | 0.43 | Out |
Put | ACAD250321P00014000 | 2 | 14.0 | 0.0 - 1.3 | 0.45 | Out |
Put | ACAD250321P00015000 | 62 | 15.0 | 0.25 - 0.7 | 0.37 | Out |
Put | ACAD250321P00016000 | 337 | 16.0 | 0.0 - 0.75 | 0.9 | Out |
Put | ACAD250321P00017000 | 375 | 17.0 | 0.0 - 1.45 | 1.05 | Out |
Put | ACAD250321P00018000 | 81 | 18.0 | 0.0 - 2.2 | 1.6 | In |
Put | ACAD250321P00019000 | 303 | 19.0 | 0.0 - 2.85 | 1.5 | In |
Put | ACAD250321P00020000 | 2 | 20.0 | 2.0 - 3.3 | 2.52 | In |
Put | ACAD250321P00021000 | 0 | 21.0 | 2.9 - 4.9 | 2.9 | In |
Put | ACAD250321P00022000 | 0 | 22.0 | 3.1 - 6.0 | 3.1 | In |
Put | ACAD250321P00023000 | 0 | 23.0 | 3.2 - 6.6 | 3.2 | In |
Put | ACAD250321P00024000 | 0 | 24.0 | 5.5 - 8.0 | 5.5 | In |
Put | ACAD250321P00025000 | 1 | 25.0 | 6.1 - 8.9 | 6.7 | In |
Put | ACAD250321P00026000 | 0 | 26.0 | 6.8 - 10.1 | 6.8 | In |
Put | ACAD250321P00027000 | 0 | 27.0 | 7.4 - 11.2 | 7.4 | In |
Put | ACAD250321P00030000 | 0 | 30.0 | 11.0 - 14.0 | 11.0 | In |
Put | ACAD250321P00035000 | 0 | 35.0 | 16.3 - 18.6 | 16.3 | In |
ACADIA Pharmaceuticals Selling And Marketing Expenses Over Time
Selling And Marketing Expenses |
| Timeline |
ACADIA Pharmaceuticals Market Cap Over Time
Market Cap |
| Timeline |
ACADIA Total Stockholder Equity
Total Stockholder Equity |
|
ACADIA Pharmaceuticals Corporate Management
| Parag PharmD | Senior Franchise | Profile | |
| Elizabeth Thompson | Executive Development | Profile | |
| Bob Mischler | Senior Strategy | Profile | |
| Albert Kildani | Senior Communications | Profile | |
| Douglas MD | Executive Development | Profile | |
| James Kihara | Chief VP | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ACADIA Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade ACADIA Stock refer to our How to Trade ACADIA Stock guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ACADIA Pharmaceuticals. If investors know ACADIA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ACADIA Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 28.347 | Earnings Share 0.78 | Revenue Per Share | Quarterly Revenue Growth 0.183 | Return On Assets |
The market value of ACADIA Pharmaceuticals is measured differently than its book value, which is the value of ACADIA that is recorded on the company's balance sheet. Investors also form their own opinion of ACADIA Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is ACADIA Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ACADIA Pharmaceuticals' market value can be influenced by many factors that don't directly affect ACADIA Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ACADIA Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if ACADIA Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ACADIA Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.